Template:21-hydroxylase deficiency: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(6 intermediate revisions by 2 users not shown)
Line 3: Line 3:
| colspan="1" style="text-align:center; background:DarkGray" |
| colspan="1" style="text-align:center; background:DarkGray" |


'''21-Hydroxylase Deficiency Microchapters
'''[[Congenital adrenal hyperplasia|Congenital adrenal hyperplasia main page]]'''
'''
|- bgcolor="LightGrey"
!
 
|-
| colspan="1" style="text-align:center; background:DarkGray" |
 
'''21-hydroxylase deficiency Microchapters
'''
'''
|- bgcolor="LightGrey"
|- bgcolor="LightGrey"
Line 10: Line 18:
|- bgcolor="LightCoral"
|- bgcolor="LightCoral"
!
!
[[21-Hydroxylase Deficiency|Home]]
[[21-hydroxylase deficiency|Home]]
|-  
|-  
!
!
Line 16: Line 24:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[21-Hydroxylase Deficiency (patient information)|Patient Information]]
[[21-hydroxylase deficiency (patient information)|Patient Information]]
|-  
|-  
!
!
Line 22: Line 30:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[21-Hydroxylase Deficiency overview|Overview]]
[[21-hydroxylase deficiency overview|Overview]]
|-  
|-  
!
!
Line 28: Line 36:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[21-Hydroxylase Deficiency historical perspective|Historical Perspective]]
[[21-hydroxylase deficiency historical perspective|Historical Perspective]]
|-  
|-  
!
!
Line 34: Line 42:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[21-Hydroxylase Deficiency classification|Classification]]
[[21-hydroxylase deficiency classification|Classification]]
|-  
|-  
!
!
Line 40: Line 48:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[21-Hydroxylase Deficiency pathophysiology|Pathophysiology]]
[[21-hydroxylase deficiency pathophysiology|Pathophysiology]]
|-  
|-  
!
!
Line 46: Line 54:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[21-Hydroxylase Deficiency causes|Causes]]
[[21-hydroxylase deficiency causes|Causes]]
|-  
|-  
!
!
Line 52: Line 60:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[21-Hydroxylase Deficiency differential diagnosis|Differentiating 21-Hydroxylase Deficiency from other Diseases]]
[[21-hydroxylase deficiency differential diagnosis|Differentiating 21-Hydroxylase Deficiency from other Diseases]]
|-  
|-  
!
!
Line 58: Line 66:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[21-Hydroxylase Deficiency epidemiology and demographics|Epidemiology and Demographics]]
[[21-hydroxylase deficiency epidemiology and demographics|Epidemiology and Demographics]]
|-  
|-  
!
!
Line 64: Line 72:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[21-Hydroxylase Deficiency risk factors|Risk Factors]]
[[21-hydroxylase deficiency risk factors|Risk Factors]]
|-  
|-  
!
!
Line 70: Line 78:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[21-Hydroxylase Deficiency screening|Screening]]
[[21-hydroxylase deficiency screening|Screening]]
|-  
|-  
!
!
Line 76: Line 84:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[21-Hydroxylase Deficiency natural history, complications and prognosis|Natural History, Complications and Prognosis]]
[[21-hydroxylase deficiency natural history, complications and prognosis|Natural History, Complications and Prognosis]]
|-  
|-  
!
!
Line 88: Line 96:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[21-Hydroxylase Deficiency history and symptoms|History and Symptoms]]
[[21-hydroxylase deficiency history and symptoms|History and Symptoms]]
|-  
|-  
!
!
Line 94: Line 102:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[21-Hydroxylase Deficiency physical examination|Physical Examination]]
[[21-hydroxylase deficiency physical examination|Physical Examination]]
|-  
|-  
!
!
Line 100: Line 108:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[21-Hydroxylase Deficiency laboratory findings|Laboratory Findings]]
[[21-hydroxylase deficiency laboratory findings|Laboratory Findings]]
|-  
|-  
!
!
Line 106: Line 114:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[21-Hydroxylase Deficiency molecular genetic studies|Molecular Genetic Studies]]
[[21-hydroxylase deficiency x ray|X Ray]]
|-  
|-  
!
!
Line 112: Line 120:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[21-Hydroxylase Deficiency genotyping|Genotyping]]
[[21-hydroxylase deficiency CT|CT]]
|-  
|-  
!
!
Line 118: Line 126:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[21-Hydroxylase Deficiency pelvic x ray|Pelvic X Ray]]
[[21-hydroxylase deficiency MRI|MRI]]
|-  
|-  
!
!
Line 124: Line 132:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[21-Hydroxylase Deficiency CT|CT]]
[[21-hydroxylase deficiency ultrasound|Ultrasound]]
|-  
|-  
!
!
Line 130: Line 138:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[21-Hydroxylase Deficiency ultrasound|Ultrasound]]
[[21-hydroxylase deficiency other imaging findings|Other Imaging Findings]]
|-  
|-  
!
!
Line 136: Line 144:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[21-Hydroxylase Deficiency other imaging findings|Other Imaging Findings]]
[[21-hydroxylase deficiency other diagnostic studies|Other Diagnostic Studies]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[21-Hydroxylase Deficiency other diagnostic studies|Other Diagnostic Studies]]
|-  
|-  
!
!
Line 154: Line 156:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[21-Hydroxylase Deficiency medical therapy|Medical Therapy]]
[[21-hydroxylase deficiency medical therapy|Medical Therapy]]
|-
!
 
|- bgcolor="PaleTurquoise"
!
[[21-Hydroxylase Deficiency surgery|Surgery]]
|-  
|-  
!
!
Line 166: Line 162:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[21-Hydroxylase Deficiency social issues|Social Issues]]
[[21-hydroxylase deficiency surgery|Surgery]]
|-  
|-  
!
!
Line 172: Line 168:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[21-Hydroxylase Deficiency primary prevention|Primary Prevention]]
[[21-hydroxylase deficiency primary prevention|Primary Prevention]]
|-  
|-  
!  
!  
Line 178: Line 174:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[21-Hydroxylase Deficiency secondary prevention|Secondary Prevention]]
[[21-hydroxylase deficiency secondary prevention|Secondary Prevention]]
|-  
|-  
!  
!  
Line 184: Line 180:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[21-Hydroxylase Deficiency cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
[[21-hydroxylase deficiency cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-  
|-  
!  
!  
Line 190: Line 186:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[21-Hydroxylase Deficiency future or investigational therapies|Future or Investigational Therapies]]
[[21-hydroxylase deficiency future or investigational therapies|Future or Investigational Therapies]]
|-  
|-  
!  
!  
Line 202: Line 198:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[21-Hydroxylase Deficiency case study one|Case #1]]
[[21-hydroxylase deficiencycase study one|Case #1]]
|-  
|-  
!
!

Latest revision as of 16:18, 24 September 2017